Tumor-targeting Salmonella typhimurium A1-R in combination with trastuzumab eradicates HER-2-positive cervical cancer cells in patient-derived mouse models

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Hiroshima, Yukihiko ^a,b,c   Zhang, Yong ^a   Zhao, Ming ^a   Zhang, Nan ^a   Murakami, Takashi ^c   Maawy, Ali ^b   Mii, Sumiyuki ^a,b   Uehara, Fuminari ^a,b   Yamamoto, Mako ^a,b   Miwa, Shinji ^a,b   Yano, Shuya ^a,b   Momiyama, Masashi ^c   Mori, Ryutaro ^c   Matsuyama, Ryusei ^c   Chishima, Takashi ^c   Tanaka, Kuniya ^c   Ichikawa, Yasushi ^c   Bouvet, Michael ^b   Endo, Itaru ^c   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; SALMONELLA TYPHIMURIUM A1 R; TRASTUZUMAB; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; MONOTHERAPY; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN EXPRESSION; STROMA CELL; UTERINE CERVIX CANCER; WEIGHT REDUCTION; ANIMAL; DISEASE MODEL; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; UTERINE CERVICAL NEOPLASMS; XENOGRAFT;

MUS; MUS MUSCULUS; SALMONELLA TYPHIMURIUM;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; RECEPTOR, ERBB-2; SALMONELLA TYPHIMURIUM; TRANSPLANTATION, HETEROLOGOUS; TRASTUZUMAB; UTERINE CERVICAL NEOPLASMS;

EID: 84934935156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120358     Document Type: Article

References (33)

1. Wang CW, Wu TI, Yu CT, Wu YC, Teng YH, Chin SY, et al. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung. Am J Clin Pathol 2009; 131:715-722. doi: 10.1309/AJCPTPBC6V5KUITM PMID: 19369633
2. Sabatier R, Roussin C, Riviere JP, Jalaguier A, Jacquemier J, Bertucci F. Breast metastasis of a squamous cell carcinoma of the uterine cervix mimicking inflammatory breast cancer. Case Rep Oncol 2012; 5:464-470. doi: 10.1159/000342255 PMID: 23109923
3. Gamez RG, Jessurun J, Berger MJ, Pambuccian SE. Cytology of metastatic cervical squamous cell carcinoma in pleural fluid: report of a case confirmed by human papillomavirus typing. Diagn Cytopathol 2009; 37:381-387. doi: 10.1002/dc.21027 PMID: 19217045
4. Hashimoto K, Yonemori K, Katsumata N, Hirakawa A, Hirata T, Yamamoto H, et al. Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma. Eur J Obstet Gynecol Reprod Biol 2011; 159:394-398. doi: 10.1016/j.ejogrb.2011.07.001 PMID: 21831511
5. Yan M, Parker BA, Schwab R, Kurzrock R. HER-2 aberrations in cancer: Implications for therapy. Cancer Treat Rev 2014; 40:770-780. doi: 10.1016/j.ctrv.2014.02.008 PMID: 24656976
6. Costa MJ, Walls J, Trelford JD. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease. Am J Clin Pathol 1995; 104:634-642. PMID: 8526205
7. Kihana T, Tsuda H, Teshima S, Nomoto K, Tsugane S, Sonoda T, et al. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer 1994; 73:148-153. PMID: 7506116
8. Hiroshima Y, Zhang Y, Zhang M, Maawy AA, Mii S, Yamamoto M, et al. Establishment of a patient-derived orthotopic xenograph (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLOS ONE, in press.
9. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005; 102:755-760. PMID: 15644448
10. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007; 104:10170-10174. PMID: 17548809
11. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, et al. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006; 66:7647-7652. PMID: 16885365
12. Zhang Y, Tome Y, Suetsugu A, Zhang L, Zhang N, Hoffman RM, et al. Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice. Anticancer Res 2012; 32:2501-2508. PMID: 22753706
13. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, et al. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009; 29:1873-1878. PMID: 19528442
14. Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, et al. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 2010; 164:248-255. doi: 10.1016/j.jss.2009.02.023 PMID: 19766244
15. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, Uehara F, et al. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 2013; 12:2774-2780. doi: 10.4161/cc.25872 PMID: 23966167
16. Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, et al. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem 2014; 115:1254-1261. doi: 10.1002/jcb.24769 PMID: 24435915
17. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, et al. Targeted therapy of spinal cord glioma with a genetically-modified Salmonella typhimurium. Cell Prolif 2010; 43:41-48. doi: 10.1111/j.1365-2184.2009.00652.x PMID: 19922490
18. Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, et al. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 2012; 11:628-632. doi: 10.4161/cc.11.3.19116 PMID: 22274398
19. Zhao M, Suetsugu A, Ma H, Zhang L, Liu F, Zhang Y, et al. Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice. Cell Cycle 2012; 11:187-193. doi: 10.4161/cc.11.1.18667 PMID: 22186786
20. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009; 106:992-998. doi: 10.1002/jcb.22078 PMID: 19199339
21. Miwa S, Zhang Y, Baek K-E, Uehara F, Yano S, Yamamoto M, et al. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R. Oncotarget 2014; 5:12849-12861. PMID: 25528763
22. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 2009; 8:870-875. PMID: 19221501
23. Matsumoto Y, Miwa S, Zhang Y, Hiroshima Y, Yano S, Uehara F, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R on nude mouse models of metastatic and disseminated human ovarian cancer. J Cell Biochem 2014; 115:1996-2003. doi: 10.1002/jcb.24871 PMID: 24924355
24. Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, et al. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem 2014; 115:1254-1261. doi: 10.1002/jcb.24769 PMID: 24435915
25. Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992; 127:1335-1339. PMID: 1359851
26. Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, et al. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy. Cell Cycle 2014; 13:3958-3963. doi: 10.4161/15384101.2014.964115 PMID: 25483077
27. Fu X, Besterman JM, Monosov A, Hoffman RM. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA1991; 88:9345-9349. PMID: 1924398
28. Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically from histologically intact patient specimens. Proc Natl Acad Sci USA 1992; 89:5645-5649. PMID: 1608975
29. Wang X, Fu X, Hoffman RM. A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int. J. Cancer 1992; 51:992-995. PMID: 1639545
30. Fu X, Hoffman RM. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 1993; 13:283-286. PMID: 8517640
31. Fu X, Le P, Hoffman RM. A metastatic-orthotopic transplant nude-mouse model of human patient breast cancer. Anticancer Res 1993; 13:901-904. PMID: 8352558
32. Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer 1993; 53:608-612. PMID: 8436434
33. Gros S, Kurschat N, Dohrmann T, Reichelt U, Dancau A-M, Peldschus K, et al. Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma. Mol Cancer Ther 2010; 9:2037-2045. doi: 10.1158/1535-7163.MCT-10-0209 PMID: 20606043